期刊文献+

宫颈疾病筛查项目在妇科专项体检中的应用状况 被引量:1

下载PDF
导出
摘要 目的探讨宫颈疾病筛查项目在妇科专项体检中的应用状况。方法根据宫颈疾病病理症状表现,选取100例宫颈疾病患者作为临床研究对象,对100例宫颈疾病患者调查其宫颈疾病筛查项目状况,分析并讨论。结果妇科专项体检者70例,占妇女健康体检总数的70.00%,检测方法相比较,行液基超薄技术联合高危型人乳头状瘤病毒检出率最高。(p<0.05)数据结果有统计学意义。结论此技术在妇科疾病筛查中使用,效果良好,值得在妇科宫颈癌临床中推广运用。 Objective:Explore applications of cervical disease screening program in gynecological examination of the special.Methods:Selected 100 cases of cervical disease patients as a clinical study, 100 patients with cervical diseases investigate cervical disease screening programs, and to analyze and discuss.Result:Special gynecological examination were 70 cases, accounting for 70.00% of the total number of women's health examination, a single line of ultra-thin liquidbased technology to detect items accounted for 10.00% of the total number of gynecological examination, thin line of liquid-based technology combined with high-risk human papillomavirus 20.00 %.(P <0.05) were statistically significant data results.Conclusion:This technique is used in gynecological screening to good effect, it is worth gynecological cancer in clinical use in the promotion.
作者 王雷 王莉莉
出处 《生物技术世界》 2015年第7期107-108,共2页 Biotech World
关键词 宫颈疾病 妇科专项体检 单一行液基超薄技术 人乳头状瘤病毒 cervical disease,gynecological examination special single row Thin Prep technique the human papilloma virus
  • 相关文献

参考文献3

二级参考文献23

  • 1邬素芳,易诚青,徐茜,王薇,辜海念,卢运萍,马丁.杂交捕获二代法检测高危型人乳头瘤病毒DNA的意义[J].中国实用妇科与产科杂志,2006,22(3):181-183. 被引量:15
  • 2邹倩,濮德敏,周利平,杜鹃,张惠萍,王忠琴,卢运萍.液基超薄细胞技术及TBS系统检测2635例宫颈涂片的临床分析[J].中国实用妇科与产科杂志,2006,22(4):268-270. 被引量:52
  • 3陈玉申,付秀娅,叶咏心.影响京港女性是否定期进行宫颈涂片检查的因素调查[J].中国全科医学,2006,9(13):1120-1120. 被引量:9
  • 4Yang BH,Bray FI,Parkin DM,et al.Cervical cancer as a priority for prevention in different world regions:an evaluation using years of life lost.Int J Cancer,2004,109:418-424.
  • 5Parkin DM,Bray F,Ferlay J,et al.Global Cancer Statistics,2002.CA Cancer J Clin,2005,55:74-108.
  • 6Murphy GP,Lawerence W,Lenhard RE,et al.American Cancer Siety textbook of clinic.Ontology,2009,5:33-35.
  • 7Parkin DM, Bray F, Ferlay J, et ag. Global cancer statistics,2002[J]. CA Cancer J Clin,2005,55(2):74 - 108.
  • 8Denny L, Quinn M, Sankaranarayanan R. Screening for cervical cancer in developing countries [J]. Vaccine,2006, 24(S3) :71 - 77.
  • 9Vijayaraghavan A, Efrusy M, Lindeque G, et al. Cost effectiveness of high risk HPV DNA testing for cervical cancer screening in South Africa [J]. Gyrzecol (hzc ,2009, 112(2) :377 - 383.
  • 10Levin CE, Sellors J, Shi J F, et al. Cost effectiveness analysis of cervical cancer prevention based on a rapid human papillomavirus screening test in a high risk region of China[J]. Int J Cancer,201 O, 127 (6) : 1404 - 1411.

共引文献19

同被引文献2

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部